|
|
| (2 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Isosorbide dinitrate#Package and Label Display Panel]] |
| {{Isosorbide dinitrate}}
| |
| {{CMG}}; {{AE}} {{PB}}
| |
| | |
| Isordil® is a registered trade mark of Biovail Laboratories International SRL.
| |
| | |
| Manufactured by:
| |
| MEDA Manufacturing GmbH
| |
| Cologne, Germany D-51063
| |
| | |
| For:
| |
| BTA Pharmaceuticals, Inc.
| |
| Bridgewater, NJ, 08807, USA
| |
| | |
| PRINCIPAL DISPLAY PANEL - 5 mg Label
| |
| | |
| NDC 64455-152-01
| |
| Isordil®5
| |
| (isosorbide dinitrate)
| |
| | |
| 5 mg
| |
| TITRADOSE™
| |
| 100 Tablets
| |
| Rx ONLY
| |
| BIOVAIL®'''
| |
| | |
| {|
| |
| |-
| |
| |[[Image:Isosorbide dinitrate2.jpg|thumb|400px]]
| |
| |-
| |
| |}
| |
| | |
| '''PRINCIPAL DISPLAY PANEL - 40 mg Label
| |
| NDC 64455-192-01
| |
| Isordil®40
| |
| (isosorbide dinitrate)
| |
| 40 mg
| |
| TITRADOSE™
| |
| 100 Tablets
| |
| Rx
| |
| ONLY
| |
| BIOVAIL®'''
| |
| | |
| {|
| |
| |-
| |
| |[[Image:Isosorbide dinitrate3.jpg|thumb|400px]]
| |
| |-
| |
| |}
| |
| | |
| | |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ISORDIL (ISOSORBIDE DINITRATE) TABLET [BTA PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abb3ad49-73a8-49c5-adc5-164d052971d7 | publisher = | date = | accessdate = 30 January 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Drugs]]
| |